The largest holder of Novartis stock is Novartis AG, with 204.3 million shares (10.04% of the company), worth about $31.16 billion as of September 25, 2026. The 10 largest holders together own 12.9%.
In Q2 2026, 1,687 institutional holdings reports listed 136.0 million shares worth $21.30 billion, down 5.6% in shares from Q1 2026.
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Novartis AG | 204.3 million | 10.04% | $31.2B |
| Sandoz Family Foundation | 42.2 million | 2.08% | $6.4B |
| Sjunde Ap Fonden (Investment Management) | 3.4 million | 0.17% | $516.0M |
| Dws Ch AG | 2.2 million | 0.11% | $340.0M |
| Basellandschaftliche Kantonalbank (Investment Management) | 2.1 million | 0.11% | $327.0M |
| Nordea Investment Management AB | 2.1 million | 0.10% | $324.0M |
| Baloise Asset Management AG | 2.0 million | 0.10% | $306.0M |
| State Street Global Advisors Ltd. | 1.8 million | 0.09% | $269.0M |
| Berner Kantonalbank AG (Investment Management) | 1.7 million | 0.08% | $253.0M |
| LLB Asset Management AG | 1.4 million | 0.07% | $209.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,687 | 136.0 million | $21.3B |
| Q1 2026 | 1,654 | 144.0 million | $22.0B |
| Q4 2025 | 1,565 | 134.0 million | $18.4B |
| Q3 2025 | 1,457 | 135.0 million | $17.3B |
| Q2 2025 | 1,433 | 134.0 million | $16.2B |
| Q1 2025 | 1,405 | 139.0 million | $15.4B |
| Q4 2024 | 1,382 | 131.0 million | $12.7B |
| Q3 2024 | 1,358 | 133.0 million | $15.2B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Novartis AG, with 10.04% of the company (as of September 25, 2026). Next: Sandoz Family Foundation (2.08%) and Sjunde Ap Fonden (Investment Management) (0.17%).
1,687 institutional holdings reports listed Novartis shares in Q2 2026, 136.0 million shares in all worth $21.30 billion.